A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516911-26-00

Acronym

CINE963A02103

Enrollment

Registered

2025-04-09

Start date

2025-05-07

Completion date

Unknown

Last updated

2025-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026